Brandinium

Trademark search for:

BIOMEBA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-12-22 — Application filed
  • 2017-05-25 — Sn assigned for sect 66a appl from ib
  • 2017-05-30 — Application filed
  • 2017-05-30 — Assigned to examiner
  • 2017-06-03 — Application filed
  • 2017-06-06 — Approved for pub - principal register
  • 2017-06-28 — Notice of publication
  • 2017-07-18 — Published for opposition
  • 2017-10-03 — Registered-principal register
  • 2017-11-02 — Grant of protection created, to be sent to ib
  • 2017-11-20 — Generic madrid transaction created
  • 2017-11-20 — Generic madrid transaction sent to ib
  • 2017-12-22 — Notification processed by ib
  • 2019-11-14 — New representative at ib received
  • 2024-04-19 — Cancelled section 71
  • 2024-04-19 — Final status recorded
  • 2024-12-20 — Total invalidation of reg ext protection created
  • 2025-02-24 — Generic madrid transaction sent to ib
  • 2025-02-24 — Generic madrid transaction created
  • 2025-04-04 — Total invalidation processed by the ib

Owner Information

AMOEBA, Société Anonyme à directoire et conseil de surveillance
FR
AMOEBA, Société Anonyme à directoire et conseil de surveillance
FR
AMOEBA, Société Anonyme à directoire et conseil de surveillance
FR

Correspondent

CABINET PLASSERAUD, Mme. ISABELLE MEUNIER-COEUR
235 Cours Lafayette
F-69006 LYON--6E--ARRONDISSEMENT,
FRANCE

Filing Details

Filing Date:
2016-12-22
Status Date:
2024-04-19
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.